Masahiro Yasunaga

12PUBLICATIONS
29CO-AUTHORS
Molecular targetsAcceleratorsCancer therapy (excl. chemotherapy and radiation therapy)Industrial molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 16, 2026
Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis.

|Mar 01, 2026
Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 Radioimmunotherapy.

Hiroki Takashima, Ryo Tsumura, Yoshikatsu Koga

|Oct 01, 2025
Near-Infrared Photoimmunotherapy Targeting Esophagogastric Junction Adenocarcinoma With Fully Human Anti-EpCAM Antibody.

Maasa Sasabe, Kenji Takashima, Shingo Sakashita

|Oct 25, 2024
Potential Mechanisms of Interstitial Lung Disease Induced by Antibody-Drug Conjugates Based on Quantitative Analysis of Drug Distribution.

Shigehiro Koganemaru, Hirobumi Fuchigami, Chihiro Morizono

|Sep 25, 2024
Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models.

Ryo Tsumura, Takahiro Anzai, Yoshikatsu Koga

|Dec 20, 2023
Bispecific Antibodies Produced via Chemical Site-Specific Conjugation Technology: AJICAP Second-Generation.

Tomohiro Fujii, Kenichiro Ito, Kazutoshi Takahashi

Pageof 2

Frequent Collaborators

6 joint publications

Hiroki Takashima

5 joint publications

Shino Manabe

3 joint publications

Yoshikatsu Koga

2 joint publications

Ryo Tsumura